Efflux in bacteria is a ubiquitous mechanism associated with resistance to antimicrobials agents. Efflux pump inhibitors (EPIs) have been developed to inhibit efflux mechanisms and could be a good alternative to reverse colistin resistance, but only CCCP has shown good activity. The aim of our study was to identify CCCP activity in a collection of 93 Gram-negative bacteria with known and unknown colistin resistance mechanisms including isolates with mcr-1 plasmid-mediated colistin resistance.
Introduction
Efflux in bacteria is a ubiquitous mechanism to combat antibiotic therapy. 1 Multidrug pumps are often non-specific, leading to cross-resistance with several antimicrobial compounds, and can interact synergistically with other resistance mechanisms in order to increase the resistance level. Colistin resistance mechanisms are complex and involve many genes that have not yet been fully identified. 2 A well-known, identified mechanism involves reducing the negative charge of the outer membrane by adding positive charges such as sugars (phosphoethanolamine, aminoarabinose) to lipid A of the lipopolysaccharide, resulting in the decreased electrostatic attraction of polymyxins. 3 Several mutations in genes such as the two-component systems pmrA/pmrB and phoP/phoQ, the negative regulator of PhoP/PhoQ, mgrB and the aminoarabinose biosynthesis operon arnBCADTEF have been involved in colistin resistance. 3 Recently, a transferable colistin-resistance gene mcr-1, which codes for a phosphoethanolamine transferase, has been discovered and appears to have already spread worldwide. 2 Colistin resistance in Gram-negative bacteria has emerged over the last few years with its increasing use in human medicine, but also its wide use in agriculture, especially in animal breeding. 4, 5 In some bacteria, efflux pump mechanisms have been reported to play a role in colistin resistance. Many efflux pumps have been identified as reducing colistin susceptibility, such as KpnEF and the AcrAB-TolC complex. 2, 3, 6 These mechanisms often lead to resistance to other antimicrobial compounds such as aminoglycosides and fluoroquinolones. Various efflux pump inhibitors (EPIs) have been tested on Gram-negative bacteria such as CCCP, 2,4-dinitrophenol (DNP), PABN, reserpine, omeprazole and verapamil. 1 Only CCCP and DNP, which inhibit the energy of efflux pumps, showed a significant decrease in colistin resistance. 7 The effect of EPIs such as CCCP in the colistin resistance reversion of Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia 7 supported the hypothesis that Baron and Rolain this mechanism plays a role in colistin resistance. More recently, colistin resistance reversion by CCCP has also been demonstrated in the naturally colistin-resistant species Serratia marcescens. 8 In our laboratory, we isolated a collection of well-defined colistinresistant strains including naturally resistant Gram-negative bacteria and acquired-resistance bacteria (mcr-1, mgrB, pmrAB, etc.). The mechanisms of resistance for some of these strains are, however, still unknown. The objective of our study was to evaluate the effect of CCCP on this group in order to evaluate whether the mechanism of resistance can influence the response to efflux pump inhibition and to evaluate its effect on mcr-1 plasmid-mediated colistin-resistant strains.
Materials and methods

Bacterial strains and colistin resistance mechanisms
Strains used in this study are listed in Table 1 . Ninety-two strains isolated from various human and pig samples were included in this study. Samples came from France, Laos, Thailand, Nigeria, Algeria and Saudi Arabia ( Table 1) . Some of these strains have already been published ( Table 1) . Mechanisms of resistance to colistin have been studied previously with the analysis of phoP, phoQ, pmrA, pmrB, mgrB and mcr-1 performed by realtime PCR, standard PCR and/or sequencing. [9] [10] [11] Two reference strains of Escherichia coli, one susceptible to colistin (ATCC 25922) and one mcr-1-positive strain (NCTC 13846), were used as controls. The mcr-1-positive strain has been included in the statistical analysis.
Effect of CCCP on colistin MIC using the broth microdilution method
Exploration of the effect of the oxidative phosphorylation uncoupler CCCP on colistin MIC was performed as follows: MIC determination of colistin was performed according to EUCAST recommendations using the broth microdilution method. Colistin sulphate salt (MP-Biomedicals, LLC, Illkirch Graffenstaden, France) concentrations ranged from 0.25 to 256 mg/L. Two tests were performed in parallel: one without adding CCCP and one adding CCCP to each CAMHB well. A stock solution of CCCP was prepared at 5 mg/mL in DMSO. The final concentration of CCCP in the CAMHB was 10 mg/L with a DMSO concentration of 0.2%. 7 A growth control well containing 10 mg/L CCCP in CAMHB was also added for each strain, in order to check the absence of effect of CCCP alone on these strains. Visualization of bacterial growth was done by adding iodonitrotetrazolium to wells.
The resulting MIC fold changes after the addition of CCCP was calculated as the ratio of the CCCP-free antibiotic's MIC level to that of the CCCP-added antibiotic. As previously described, 8 the positive criterion for the presence of efflux pumps in isolates was an !8-fold decrease in colistin MIC after adding CCCP. The mean fold change was calculated by species and by colistin resistance mechanism identified as previously described: where the 'frequency of fold change' is the number of times a particular MIC fold change was recorded for that species. The symbol of superiority for MIC fold changes was considered as an equal for the mean fold change analysis. Statistical analyses were performed using non-parametric oneway analysis of variance (ANOVA) (GraphPad Software Inc., La Jolla, CA, USA). A P value ,0.05 was taken into account for the MIC fold change. The resulting MIC after adding CCCP was compared to the EUCAST cutoff (established at 2 mg/L) and the effect was considered reversed if the strain became susceptible to colistin again. S. enterica Colistin susceptibility testing was performed according to EUCAST recommendations using the Etest (bioMérieux, Marcy-l'Étoile, France) or the disc diffusion method on MH agar with commercial antibiotic discs (bioMérieux). Initially, Etests were performed on S. marcescens in order to better visualize the 'cocarde' effect, 12 which corresponds to an absence of inhibition next to the disc surrounded by a ring of inhibition close to the edge of the bacterial growth unaffected by the antibiotic. The withdrawal from the market of Etests forced us to use the disc method for the other species (http://ansm.sante.fr/var/ansm_site/storage/original/application/7e5c2 9808ae0bc4d37761e98cc8eeb06.pdf). Colistin MIC was determined on two types of media: MH agar with DMSO, and MH agar with 10 mg/L CCCP (Sigma-Aldrich, Saint-Quentin-Fallavier, France) dissolved in DMSO. When a strain was totally inhibited by colistin ! CCCP, a plate containing 10 mg/L CCCP only was used to confirm the absence of effect of the EPI alone.
The significance of the change in diameter of colistin inhibition by the disc diffusion method with and without CCCP was evaluated by a Student's t-test in a matched series. Results were considered as statistically significant when they had a P value ,0.05. S. marcescens results were considered separately as the MIC was determined on an agar plate for this species and a fold change was calculated as described above.
Time-kill study
A time-kill study was performed on one strain of each colistin resistance mechanism group, namely, K. pneumoniae FHM169 (mgrB stop), E. coli 44A (mcr-1 positive), Proteus vulgaris P97 (intrinsically resistant to colistin), Enterobacter asburiae LH74 and K. pneumoniae KP4CR (unknown resistance). A fresh culture of bacteria was inoculated in the three following conditions: CAMHB ! DMSO, MH broth ! colistin (2 mg/L) and CAMHB ! colistin (2 mg/L) ! CCCP (10 mg/L) and incubated for 24 h at 37 C with shaking. At times 0 h, 30 min, 1 h, 2 h, 4 h, 8 h and 24 h, several dilutions of each culture were spread on Trypticase soya agar and incubated for 24 h before colony counting.
RNA expression
In order to evaluate the impact of CCCP on mcr-1 gene transcription, we quantified mcr-1 RNA in two mcr-1-positive E. coli strains, 44A and P10. We inoculated fresh colonies into three different LB broth cultures, Baron and Rolain containing DMSO, 2 mg/L colistin ! DMSO or 2 mg/L colistin ! 10 mg/L CCCP, that were incubated at 37 C with shaking for 4 h. One millilitre of this culture, calibrated to an OD of 0.19 (corresponding to $1 % 10 8 cfu/mL), was extracted using the TRIzol V R Max TM Bacterial RNA isolation Kit (Thermo Fisher, Waltham, MA, USA). Briefly, after centrifugation, the pellet was resuspended with 700 lL of TRIzol and 50 lL of 4-bromoanisole (BAN). After 15 min of centrifugation at 4 C at 12 000 g, the aqueous phase containing the RNA was suspended in a new Eppendorf tube and precipitated using 500 lL of isopropanol. The RNA was then washed with 75% ethanol and suspended in 30 lL of water after centrifugation. This RNA was purified from the remaining DNA using the DNA-free TM kit procedure (Thermo Fisher) following the recommendations of the manufacturer. Finally, 20 lg of the RNA was used to quantify gene expression using the SuperScript TM III Platinum One-Step qRT-PCR Kit (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. Each quantification was performed in duplicate. The DDCt method was used to quantify gene expression. The dxS housekeeping gene was used as calibrator using the following primers: F-GCTTCACAATGCCTTTGCCA, R-TATAACGATGGCCCGTCAGC and the following probe: 6 FAM-CGTCAGTTCCACGCCGACCG whereas the mcr-1 primers and probe were those previously described.
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Results
We tested the effect of CCCP on 91 Enterobacteriaceae including 32 K. pneumoniae, 26 E. coli, 6 Enterobacter spp., 2 Salmonella enterica, 1 Klebsiella oxytoca, 14 S. marcescens, 3 Morganella morganii, 3 Proteus spp., 4 Providencia spp. and 3 P. aeruginosa. All strains, except for the colistin-susceptible reference strain ATCC 25922, were found to be resistant to colistin, with an MIC between 4 and .256 mg/L ( Table 1) . Mechanisms of resistance to colistin had already been identified in some of the strains studied (Table 1) .
All isolates used in this study grew in the presence of CCCP at the concentration of 10 mg/L in DMSO without any colistin, in broth medium and on agar plates, confirming that this substance alone has no effect at this concentration on these Gram-negative bacteria (Figure 1) . 7 Of the 93 strains tested, 90 strains had an MIC fold change !8, confirming the presence of the efflux pump mechanism of resistance. Only two strains of K. pneumoniae showed an MIC fold change ,8, but their colistin MICs were low (2 and 4 mg/L, respectively) and a reversal effect was still observed after adding colistin (0.5 and 1 mg/L, respectively). Likewise, the addition of CCCP led to reversed colistin resistance (MIC ,2 mg/L) in all the strains studied. The mean fold change determined by species varied from 24 for S. enterica to 1024 for colistin-heteroresistant Enterobacter (Table 2) . We noticed that the effect of CCCP on intrinsically resistant bacteria was much greater than on other Enterobacteriaceae (P , 0.0001).
We then decided to compare the impact of CCCP according to the mechanism of resistance identified. Bacteria were separated between 'intrinsic' or 'natural' resistance, 'heteroresistance', which describes a phenomenon where subpopulations of seemingly isogenic bacteria exhibit a range of susceptibilities to a particular antibiotic, 13 'mcr-1 plasmid-mediated' resistance, 'other' resistance when the resistance was caused by a known chromosomic mutation and 'unknown' when the resistance mechanism was still unknown. By comparing the resistance mechanism (Table 3) , we observed that the efflux mechanism was significantly greater in bacteria naturally resistant to colistin and in bacteria with a heteroresistance mechanism than in bacteria with other resistance mechanisms (P , 0.0001) (Figure 2a) . On the other hand, there were no significant differences between 'intrinsic' and 'heteroresistance' groups or between 'mcr-1', 'other mutation' or 'unknown' groups ( Figure 2a) .
The effect of CCCP on agar plates showed significant CCCP activity on colistin resistance. The diameter of inhibition of colistin (mm) increased from 14.1 + 4.4 mm without CCCP to 23.5 + 5.3 mm with CCCP (P , 0.0001) (Figure 2b ). For S. marcescens strains, the fold change on agar plates with Etest MIC determination varied from 1347-fold to 4000-fold (P , 0.0001). Strains were all resistant to colistin with MIC .256 mg/L before adding CCCP, whereas colistin MIC values after adding CCCP varied from 0.064 to 0.19 mg/L (mean 0.128 mg/L). However, no correlation between the disc diffusion assay and the microdilution method was observed. This can be explained by the fact that the disc diffusion method is not a relevant method to determine colistin susceptibility as the colistin does not diffuse correctly in an agar plate. 14 Analyses of the time-kill study showed that the association of colistin ! CCCP was bacteriostatic on the five strains tested (Figure 3) . No difference was observed between the strains with CCCP reversing colistin resistance in Gram-negative bacteria JAC different resistance mechanisms. This is concordant with a previous time-kill study done on K. pneumoniae 7 that showed an inhibiting effect on bacterial growth, but no killing effect.
Finally, the effect of the association of colistin ! CCCP on mcr-1 gene expression was performed on two mcr-1-positive E. coli. The addition of 2 mg/L colistin led to a decrease of 1.65-fold for strain 44A and to an increase of 0.84-fold for strain P10 (Figure 4) . However, the combination of 2 mg/L colistin ! 10 mg/L CCCP decreased mcr-1 expression 40.5-fold and 26.9-fold, respectively, for strain 44A and strain P10.
Discussion
The role of efflux in colistin resistance is still unknown in enterobacteria. In our study, we showed a reversal effect on colistin resistance by CCCP on all the strains studied. This effect was more significant in 'intrinsically resistant' and 'heteroresistant' enterobacteria than in other Enterobacteriaceae, suggesting that the mechanism blocked by CCCP is critical for colistin resistance in these species. Although the main mechanism described for these species is the modification of lipid A by amino sugars, susceptibility to EPIs was significantly greater in this group than in the 'other mutation' and 'mcr-1' groups for which colistin resistance is also mediated by lipid A modification. Interestingly, the time-kill study showed no differences between the different strains carrying different colistin resistance mechanisms. The association of colistin ! CCCP was bacteriostatic on all strains tested, supporting previous results observed on a colistin-resistant K. pneumoniae strain. 7 Many mechanisms have been identified so far, with the most recent, mcr-1, carried by a transferable plasmid, mostly in E. coli and K. pneumoniae. 2 The transcriptomic analysis of the mcr-1 gene in two mcr-1-positive E. coli isolates showed that the association of colistin and CCCP inhibits the transcription of the mcr-1 gene. This could likely be explained either by inhibition of Baron and Rolain efflux (CCCP increases the colistin concentration, which potentiates its effect and inhibits the transcription of the mcr-1 gene) or by an unknown action of CCCP. Efflux has been reported to play a role in colistin resistance, such as with AcrAB-TolC in E. coli 15 and MexXY-OprM in P. aeruginosa.
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EPIs have been used to evaluate the effect of efflux pump upregulation in resistance to colistin. Effects of EPIs on colistin resistance vary according to the type of EPI. For example, PABN and 1-(1-naphtylmethyl)-piperazine (NMP) are EPIs believed to act in competition with drugs in the pocket of the action site of AcrB 17 and they failed to recover colistin susceptibility in colistin-resistant Gram-negative bacteria. 7, 18 This inefficiency has also been reported for other well-known EPIs such as verapamil, omeprazole and reserpine. 7 On the other hand, CCCP and DNP, which are non-specific EPIs, showed good activity in restoring colistin susceptibility. 7, 8, 18 Therefore, it is difficult to identify the efflux pump responsible for the resistance because they act on the energy source of efflux pumps, the proton motive force, and can modulate other protein activity in the membrane. 1 Ni et al. 7 have also suggested that the CCCP effect observed on colistin activity may be due to regeneration of negative charges on the cell membrane. In another study, Park and Ko 18 hypothesized the decrease of ATP production caused by CCCP action could be responsible for increased colistin activity in these cells. Our study suggests that CCCP probably has an effect as an EPI. Moreover, the role of soxRS, a modulator of the efflux pump AcrAB-TolC, has recently been reported to be responsible for colistin resistance in Enterobacter spp. 6 TolC is an outer membrane protein that can interact with many inner membrane proteins, especially membrane fusion proteins, in order to create a channel for various protein extrusions. 19 Usually, bacteria use at least one efflux pump system in the inner membrane such as AcrAB in E. coli that, in association with TolC, enables antibiotic extrusion. Some studies showed that some drugs were dependent on TolC without being dependent on AcrAB, suggesting that TolC can be associated with other inner membrane proteins to evacuate drugs. 19 But until now, none of the studied efflux pumps could prove this hypothesis. In our study, the action of CCCP was particularly important for the heteroresistant strains. In these strains, PABN, which is known to permeabilize the outer membrane of Gram-negative bacteria, 20 showed an effect on colistin resistance in Enterobacter cloacae and in Enterobacter aerogenes, suggesting that AcrAB-TolC is up-regulated in these strains, but no effect was observed in S. marcescens strains (data not shown). Despite its resistance being similar to the heteroresistance of Enterobacter spp., some other genes seem to be involved in colistin resistance. In a study on S. marcescens, it has been shown that CCCP increases the accumulation of ciprofloxacin in a WT strain, but not in CCCP reversing colistin resistance in Gram-negative bacteria JAC an sdeB-deficient mutant. The resistance-nodulation-division tripartite efflux pump SdeAB-HasF is homologous to AcrAB-TolC and seems to be the major efflux pump system in Serratia. 21 This pump seems to extrude a wide variety of components, is dependent on proton motive force and may be a good candidate for a colistinresistance target gene. Further studies are needed on efflux pump inhibition in colistin resistance to better understand the pathways of this complex mechanism, particularly by describing efflux pump genes and their expression in susceptible/resistant/heteroresistant mutant strains. Our study further suggests that several EPIs could be developed in the future to tackle the issue of emerging colistin resistance in Gram-negative bacteria as demonstrated in the past with b-lactamase inhibitors and resistance to b-lactams. Some studies are currently trying to develop associations of EPIs with other molecules 22 to fight bacterial infections.
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